![Tim O'Brien](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tim O'Brien
No open positions remaining
Health Technology
Profile
Tim O'Brien worked as a Principal at C.
R.
Bard, Inc., St. Jude Medical LLC, Boston Scientific Corp., and Arizant, Inc. He also worked as an Engineer at Endothelix, Inc.
Former positions of Tim O'Brien
| Companies | Position | End |
|---|---|---|
| ST JUDE MEDICAL INC | Corporate Officer/Principal | - |
| C.R. BARD | Corporate Officer/Principal | - |
Arizant, Inc.
 Arizant, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and markets medical devices | Corporate Officer/Principal | - |
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | - |
Endothelix, Inc.
 Endothelix, Inc. Medical SpecialtiesHealth Technology Develops cardiovascular devices | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 5 |
|---|---|
C. R. Bard, Inc. (New Jersey)
 C. R. Bard, Inc. (New Jersey) Medical SpecialtiesHealth Technology Designs, manufactures, packages, distributes and sells medical, surgical, diagnostic & patient care devices | Health Technology |
St. Jude Medical LLC
 St. Jude Medical LLC Medical SpecialtiesHealth Technology Develops, manufactures and distributes cardiovascular medical devices | Health Technology |
Boston Scientific Corp.
 Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Arizant, Inc.
Arizant, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and markets medical devices | Health Technology |
Endothelix, Inc.
Endothelix, Inc. Medical SpecialtiesHealth Technology Develops cardiovascular devices | Health Technology |
- Stock Market
- Insiders
- Tim O'Brien
